Daewoong Pharmaceutical conducts ESG digital health medical service in Daebudo Island
Aug 20, 2025
|
It is the second medical service in the island region after Yukdo in June, meaning to provide practical health care opportunities and realize medical equity and ESG values at the same time through digital health technology. The medical volunteer group, consisting of Daewoong Pharmaceutical and six other digital health companies (Sears Technology, Arc, Exosystems, A-Slip, Everx, and Medical AI), visited Daebunam-dong Senior Citizens Hall in the 38-degree heat and conducted activities to resolve medical blind spots.
The main devices used included ▲AI blindness disease diagnosis solution 'Whiskey' and fundus camera 'Optina Genesis' ▲ wearable electrocardiogram device 'Mobicare' ▲ early diagnosis software 'Etia LVSD' ▲'Exomed-DeepSak' ▲ Musculoskeletal analysis software 'Mora View' ▲'App Note Rack'.
As a result of on-site screening based on digital healthcare devices, a number of people found were identified. In the AI fundus test (Wiskey, Optina), suspected blindness risk diseases were observed in about 40% of residents, and in the sarcopenia test (Exomed-DeepSak), about 48% were classified as suspicious and cautious, so detailed examinations were recommended. In addition, musculoskeletal examination (Mora View) confirmed posture alignment abnormalities in about 65%, guiding customized exercise in the field.
In this service, residents of Daebu Island, which is difficult to find a hospital, were able to check their health risk signals in advance and point out necessary lifestyle improvements beyond simply measuring blood pressure or blood sugar. In particular, diseases that are easy to miss in general checkups such as heart failure, arrhythmia, sarcopenia, and sleep apnea were examined early. Ultimately, it is attracting attention as a digital health-based model that can substantially contribute to resolving medical blind spots by realizing early detection and prevention-oriented health care of chronic diseases.
Cho Byung-ha, head of Daewoong Pharmaceutical's digital healthcare business division, said, "This service is part of the ESG management practice to realize the 'everyone is healthy' that Daewoong Pharmaceutical aims for. We will continue to provide assistance to places with low access to medical care and co-prosperity with local communities through digital healthcare technology." he said.
This article was translated by Naver AI translator.
